IRIS NEOVASCULARISATION

IRIS NEOVASCULARISATION was reported 125 times

These drug classes are most commonly taken by patients reporting IRIS NEOVASCULARISATION:

# Drug Count
0 Vascular Endothelial Growth Factor Inhibitor [EPC] 35
1 Corticosteroid [EPC] 18
2 Platinum-based Drug [EPC] 12
3 Complement Inhibitor [EPC] 10
4 Nonsteroidal Anti-inflammatory Drug [EPC] 10
5 Prostaglandin Analog [EPC] 10
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7
7 Carbonic Anhydrase Inhibitor [EPC] 6
8 Insulin Analog [EPC] 6
9 Folate Analog Metabolic Inhibitor [EPC] 5
10 Nucleoside Analog Antiviral [EPC] 5
11 Sulfonylurea [EPC] 5
12 CD20-directed Cytolytic Antibody [EPC] 4
13 Platelet Aggregation Inhibitor [EPC] 4
14 Angiotensin Converting Enzyme Inhibitor [EPC] 3
15 Dihydropyridine Calcium Channel Blocker [EPC] 3
16 Ester Local Anesthetic [EPC] 3
17 Glycopeptide Antibacterial [EPC] 3
18 Loop Diuretic [EPC] 3
19 Osmotic Laxative [EPC] 3
20 Phosphodiesterase 5 Inhibitor [EPC] 3
21 Proton Pump Inhibitor [EPC] 3
22 Alkylating Drug [EPC] 2
23 Amide Local Anesthetic [EPC] 2
24 Antiarrhythmic [EPC] 2
25 Anticholinergic [EPC] 2
26 Calcium Channel Blocker [EPC] 2
27 Cholinergic Muscarinic Antagonist [EPC] 2
28 Copper-containing Intrauterine Device [EPC] 2
29 GLP-1 Receptor Agonist [EPC] 2
30 Histamine-2 Receptor Antagonist [EPC] 2
31 Insulin [EPC] 2
32 Non-Standardized Chemical Allergen [EPC] 2
33 Photoenhancer [EPC] 2
34 Standardized Chemical Allergen [EPC] 2
35 Thalidomide Analog [EPC] 2
36 Topoisomerase Inhibitor [EPC] 2
37 Vitamin C [EPC] 2
38 Vitamin D [EPC] 2
39 Aluminum Complex [EPC] 1
40 Aminoglycoside Antibacterial [EPC] 1
41 Antiseptic [EPC] 1
42 Arteriolar Vasodilator [EPC] 1
43 Azole Antifungal [EPC] 1
44 Calcineurin Inhibitor Immunosuppressant [EPC] 1
45 Calcium [EPC] 1
46 Catecholamine [EPC] 1
47 Central alpha-2 Adrenergic Agonist [EPC] 1
48 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
49 Estrogen [EPC] 1
50 Factor Xa Inhibitor [EPC] 1
51 HMG-CoA Reductase Inhibitor [EPC] 1
52 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
53 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
54 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
55 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
56 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
57 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
58 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
59 Leukocyte Growth Factor [EPC] 1
60 Lipid-based Polyene Antifungal [EPC] 1
61 Melatonin Receptor Agonist [EPC] 1
62 Nucleoside Metabolic Inhibitor [EPC] 1
63 P2Y12 Platelet Inhibitor [EPC] 1
64 Polyene Antifungal [EPC] 1
65 Potassium Salt [EPC] 1
66 Proteasome Inhibitor [EPC] 1
67 Radiographic Contrast Agent [EPC] 1
68 Selective T Cell Costimulation Modulator [EPC] 1
69 Sulfonamide Antimicrobial [EPC] 1
70 Thiazide-like Diuretic [EPC] 1
71 Tumor Necrosis Factor Blocker [EPC] 1
72 Vitamin B12 [EPC] 1
73 Xanthine Oxidase Inhibitor [EPC] 1
74 alpha-Adrenergic Agonist [EPC] 1
75 beta-Adrenergic Agonist [EPC] 1
76 beta-Adrenergic Blocker [EPC] 1
77 beta3-Adrenergic Agonist [EPC] 1